Skip to main content
. 2023 Sep 2;14:5332. doi: 10.1038/s41467-023-40813-w

Fig. 2. Freedom from progression.

Fig. 2

A Freedom from progression for the entire cohort from the date of enrollment by the Kaplan–Meier method (n = 18). B Freedom from progression stratified by a dose of atezolizumab administered (n = 18). Source data are provided as a Source Data file.